Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors <b> <i>in Vivo</i> </b>
Nicole Concin(Medical University of Vienna), Ute M. Moll(Weatherford College), Christian Marth(Nordic Society of Gynecologic Oncology), K Becker(Fred Hutch Cancer Center), Alain G. Zeimet(Innsbruck Medical University), Neda Slade(Augustana University), Robert Zeillinger(Comprehensive Cancer Center Vienna), Guenter Daxenbichler(Universitätsklinik für Frauenheilkunde und Geburtshilfe), Hanno Ulmer(Innsbruck Medical University), Susan Erster(Stony Brook University), Elizabeth Mueller-Holzner(Universitätsklinik für Frauenheilkunde und Geburtshilfe)
Cited by 137
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|International Journal of Gynecological Cancer|2020|1.9k
Fractionation and turnover of stable carbon isotopes in animal tissues: Implications for ?13C analysis of diet
|Oecologia|1983|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k